Skip to content
iCo Therapeutics
  • iCo Therapeutics
  • About Us ▾
    • Our Vision and Strategy
    • Leadership and Board of Directors
    • Accomplishments
  • Current Assets ▾
    • The Problem of Drug Shortages
    • iCo-008
    • Oral Amphotericin B
  • Investor Information
    • Specific Projects
  • Contact
  • iCo Articles

2013 News Releases

2013 News Releases

Jan 3, 2013:

iCo Therapeutics Announces Positive iCo-007 Phase 2 Clinical Update

Contact Us

 About iCo

 Sitemap

  The Development of Research

© Copyright 2022 - iCo Therapeutics Inc. - All Rights Reserved.